BENOXINATE HYDROCHLORIDE - Generic Drug Details
What are the generic sources for benoxinate hydrochloride and what is the scope of patent protection?
Benoxinate hydrochloride
is the generic ingredient in three branded drugs marketed by Sola Barnes Hind, Altaire Pharms Inc, and Bausch Lomb Ireland, and is included in three NDAs. There are three patents protecting this compound. Additional information is available in the individual branded drug profile pages.Summary for BENOXINATE HYDROCHLORIDE
| US Patents: | 3 |
| Tradenames: | 3 |
| Applicants: | 3 |
| NDAs: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 77 |
| Clinical Trials: | 8 |
| Patent Applications: | 816 |
| DailyMed Link: | BENOXINATE HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for BENOXINATE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Tanta University | EARLY_PHASE1 |
| University of Campinas, Brazil | PHASE3 |
| Sintetica SA | Phase 3 |
US Patents and Regulatory Information for BENOXINATE HYDROCHLORIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bausch Lomb Ireland | FLUORESCEIN SODIUM AND BENOXINATE HYDROCHLORIDE | benoxinate hydrochloride; fluorescein sodium | SOLUTION/DROPS;OPHTHALMIC | 211039-001 | Mar 9, 2020 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Bausch Lomb Ireland | FLUORESCEIN SODIUM AND BENOXINATE HYDROCHLORIDE | benoxinate hydrochloride; fluorescein sodium | SOLUTION/DROPS;OPHTHALMIC | 211039-001 | Mar 9, 2020 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Altaire Pharms Inc | ALTAFLUOR BENOX | benoxinate hydrochloride; fluorescein sodium | SOLUTION/DROPS;OPHTHALMIC | 208582-001 | Dec 14, 2017 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
